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Editorial JCDR
In the spring of 2012, The Journal of  Cardiovascular 
Disease Research (JCDR) would be two years old, and 
we are pleased to introduce the first issue of 2012 in 
celebration. It is due to the dedicated efforts by our 
editors and reviewers that our journal is attracting high 
quality research papers from the authority in the field, 
and is becoming more and more popular amongst our 
cardiovascular profession colleagues and doctors. It gives 
us immense pleasure to see the journal grow by leaps and 
bounds, and become stronger with each passing day.
This new issue of JCDR highlights multidisciplinary 
contents, which include five original research articles, four 
clinical case report based studies and two cardiothoracic 
surgery reports. Among them, Dr. Hadi’s article about the 
anti-atherosclerotic activities of two anti-diabetic drugs 
has been commented by Dr. Kan Chen from Brigham and 
Women’s Hospital, Boston.
It is a known fact that Type II diabetes can increase the 
chances of atherosclerosis in those affected. Glimepiride 
and Repaglinide are two commonly used oral anti-diabetic 
drugs, and they act by promoting insulin secretion. In this 
issue, Hadi et al. demonstrated in rabbit models that these 
two drugs also have anti-atherosclerotic effects through the 
inhibition of the inflammation and reduction in oxidative 
stress. These findings raise the possibility of applying 
these two drugs to atherosclerotic patients, especially in 
those with type II diabetes. This investigation was further 
commented by Dr. Kan Chen from Brigham and Women’s 
Hospital, Boston.
Monosodium glutamate (MSG) as a food flavoring agent 
has been widely used in Asia since over a 100 years now. 
Singh K and Ahluwalia P studied the short term effect of 
MSG to mouse hearts. They found that MSG markedly 
decreased the enzymatic activities of superoxide dismutase, 
catalase and GSH metabolic enzymes. Therefore, MCG 
increased the oxidative stress in hearts and predisposed 
MCG-fed mice to heart disease. According to this finding, 
it is better to avoid MSG in our diet.
Cardiac syndrome X is a cardiogenic angina without 
obstructive coronary artery disease. The pathogenesis 
of cardiac syndrome X is still unknown. In this issue, 
Rasmi et al. suggested that the high rate of prevalence 
of Helicobacter pylori infection in Iranian patients with 
cardiac syndrome X, could point to the former as being 
one of the causative factors. It has been suggested that 
the interaction of non-invasive Helicobacter pylori with 
vascular endothelial cells causes chronic inflammation and 
microvascular dysfunction in the coronary arteries.
Plasma brain natriuretic peptide (BNP) level can be regarded 
as a biomarker for myocardial stress. Heart diseases such 
as cardiomyopathy, coronary artery disease and valvular 
heart disease can affect the circulating BNP level. Bordbar 
et al. showed that endurance exercise offers great advantage 
to our cardiovascular system and helps in lowering the 
circulating BNP level. This is achieved by reducing heart 
stress and increasing the cardiac contractile function.
Obesity and overweight are severe social issues, not only 
in developed countries, but also in developing countries, 
such as China and India. As per the findings by the World 
Health Organization, the prevalence of obesity and 
overweight has more than doubled since 1980. Obesity 
and overweight are major contributors to chronic diseases, 
including cardiovascular disease, type II diabetes, and even 
certain cancers. In this issue, Hassanzadeh et al. finished 
an epidemic study between obesity and overweight and 
non-communicable diseases at the Markazi province 
of Iran, a developing country. Coronary artery disease 
accounts for about 40% of premature deaths, and obesity 
and overweight, which are both preventable, are the major 
risk factors to developing such coronary artery disease 
conditions.
In clinical practice, cardiovascular diseases are often found 
to have diverse manifestations which can complicate the 
diagnosis. In this issue, we have presented four rare, however 
interesting cases, three of them are strongly associated with 
cardiac sudden death. Hypertrophic cardiomyopathy is 
featured by increased left ventricular wall thickness and is 
a major risk factor for sudden death, especially at a young 
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age. Femenia et al. presented a rare case of a teenage girl 
with idiopathic hypertrophic cardiomyopathy and rapidly 
progressive fragmented QRS. The girl was diagnosed with 
hypertrophy at the age of nine and thereafter received 
β-blocker treatment for 7 years before she was developed 
massive hypertrophy and fragmented QRS, which caused 
a cardiac arrest. She recovered well after implantable 
cardioverter defibrillator implantation and continuous 
β-blocker therapy. The researchers suggested that the 
fragmented QRS might act as a non-invasive marker test 
for ventricular arrhythmia in patients with hypertrophic 
cardiomyopathy.
Cardiac developmental mild defects are rare and hard 
to diagnose without using high-tech contemporary 
equipments. Satija et al. reported another uncommon 
cause of sudden cardiac death. Malignant abnormal right 
coronary artery, which is a rare developmental defect, can 
prove lethal; and, can be detected using multidetector 
row computed tomography with essential knowledge. In 
another case, Jain et al. reported an unusual case where 
a rupture of both, the sinus of Valsalva and subaortic 
membrane, was observed. Subaortic membrane affects the 
aortic valve and the hemodynamics of the left ventricular 
outflow, which can lead to hypertrophy or myocardium 
ischemia, and finally cause heart failure. The association 
between subaortic membrane and rupture of the sinus 
of Valsalva is still a myth. The possibilities of surgery are 
discussed by the clinicians.
In the last case report, Kota et al. shared an unusual case 
of pheochromocytoma with renal artery stenosis. They 
performed literature review, and discussed the potential 
association between pheochromocytoma and renal artery 
stenosis, and mentioned that the hypertension caused by 
catecholamines secreted by the tumor cells, and compression 
of renal artery could be the two possible causes.
When the conservative medical management approach 
fails to produce results, we may have to use the surgical 
route for a number of heart related conditions. In this 
issue, we present a retrospective study for a new stentless 
aortic valve replacement technique and one coronary 
artery bypass grafting for a patient with gout arthritis. 
Conventional stentless aortic valve prosthesis shows great 
hemodynamic benefits. However, its association with 
increased postoperative heart block suggests that newer 
techniques or modifications are urgently required. To solve 
this problem, Song et al. have presented an alternative 
subcoronary implantation technique. Their comparative 
retrospective study of two groups receiving different 
stentless aortic valve replacement surgery procedures 
showed that the new method remedies for the shortcomings 
of the conventional method. When compared with the 80 
patients operated by conventional subcoronary implantation 
technique, 50 patients who received treatment by the new 
alternative subcoronary technique had greatly reduced 
incidence of postoperative complete heart block. In 
another surgery report, Ugurlucan et al. presented the case 
where a surgery was successfully performed in a 63-year-
old patient with coronary artery disease in company with 
metabolic gout arthritis. Elevated serum uric acid levels are 
known to be associated with coronary artery disease and 
can cause gout arthritis. In patients with atherosclerosis 
causingseverely occluded coronary arteries, coronary artery 
bypass grafting may be required.
At the end of this preface, I would like to take the 
opportunity to extend my sincere acknowledgement to 
all the authors and readers of our journal, the Journal of  
Cardiovascular Disease Research, for extending their kind 
support and co-operation which truly helped the journal 
to grow and become as successful as it is today..
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